1-8 of 8
Mark Eric Kohler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual CAR Stimulation in CD19xCD22 Bicistronic CAR T Cells Results in Increased c-Jun Expression and Superior In Vivo Expansion

Alexander W. Rankin, Mark Eric Kohler
Journal: Blood
Blood (2022) 140 (Supplement 1): 10241–10242.
https://doi.org/10.1182/blood-2022-169786
Published: 2022
Journal Articles

Overexpression of Rorγt in CAR T Cells Improves Persistence and Reduces Exhaustion

Jennifer Cimons, Mark Eric Kohler, Michael Yarnell, Terry J. Fry
Journal: Blood
Blood (2021) 138 (Supplement 1): 2801.
https://doi.org/10.1182/blood-2021-147011
Published: 2021
Journal Articles

Detection of Vector Copy Number in Bicistronic CD19xCD22 CAR T Cell Products with Digital PCR

Lindsey A. Murphy, Russell Marians, Mark Eric Kohler, Terry J. Fry, Amanda C. Winters
Journal: Blood
Blood (2021) 138 (Supplement 1): 4001.
https://doi.org/10.1182/blood-2021-153889
Published: 2021
Journal Articles

Understanding the CD8+ CAR T Cell Response to Antigen-Low Leukemias

Kole Degolier, Jennifer Cimons, Michael Yarnell, Mark Eric Kohler, Terry J. Fry
Journal: Blood
Blood (2021) 138 (Supplement 1): 736.
https://doi.org/10.1182/blood-2021-151729
Published: 2021
Journal Articles

A Direct Comparison of the In Vivo Efficacy and in Vitro Signaling of Chimeric Antigen Receptors and Endogenous T Cell Receptors

Mark Eric Kohler, MD, PhD, Yinmeng Yang, PhD, Gian Sepulveda, Terry J. Fry, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4451.
https://doi.org/10.1182/blood.V130.Suppl_1.4451.4451
Published: 2017
Journal Articles

Effect of Chronic Endogenous Antigen Stimulation on CAR T Cell Persistence and Memory Formation

Yinmeng Yang, PhD, Mark Eric Kohler, MD, PhD, Terry J. Fry, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 166.
https://doi.org/10.1182/blood.V130.Suppl_1.166.166
Published: 2017
Journal Articles

Direct Comparison of Anti-CD33 and Anti-CD123 Chimeric Antigen Receptor T Cells with CD28 or 41BB Co-Stimulatory Domains for Treatment of Acute Myeloid Leukemia

Samiksha Tarun, MSc, Haiying Qin, MS, Lila Yang, BS, Christopher Daniel Chien, PhD, Mark Eric Kohler, MD PhD, Terry J. Fry, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1370.
https://doi.org/10.1182/blood.V130.Suppl_1.1370.1370
Published: 2017
Journal Articles

Modeling Retreatment of Acute Lymphoblastic Leukemia with Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

Yinmeng Yang, PhD, Mark Eric Kohler, MD PhD, Terry J Fry, MD
Journal: Blood
Blood (2016) 128 (22): 2806.
https://doi.org/10.1182/blood.V128.22.2806.2806
Published: 2016